AMLODIPINE BESYLATE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69097-127 -
Package NDC
69097-127-05 -
Package NDC
69097-127-15 -
Application number
ANDA077073 -
SPL ID
7cbe66f6-99fb-403f-9c6b-e4ecc7549eaf -
SPL set ID
5409b296-3bed-47cd-abba-9fe6f6833af6 -
UNII
864V2Q084H -
RxCUI
197361 -
RxCUI
308135 -
RxCUI
308136
What the source publishes
- Labeler
- Cipla USA Inc.
- Active ingredients
- AMLODIPINE BESYLATE
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "AMLODIPINE BESYLATE",
"splId": "7cbe66f6-99fb-403f-9c6b-e4ecc7549eaf",
"labels": [
{
"setId": "5409b296-3bed-47cd-abba-9fe6f6833af6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5409b296-3bed-47cd-abba-9fe6f6833af6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5409b296-3bed-47cd-abba-9fe6f6833af6"
}
],
"routes": [
"ORAL"
],
"labeler": "Cipla USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (69097-127-05)",
"package_ndc": "69097-127-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20070926"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (69097-127-15)",
"package_ndc": "69097-127-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20070926"
}
],
"productId": "69097-127_7cbe66f6-99fb-403f-9c6b-e4ecc7549eaf",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "69097-127",
"deaSchedule": null,
"genericName": "AMLODIPINE BESYLATE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMLODIPINE BESYLATE",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA077073",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20070926",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0369097126056",
"0369097128050",
"0369097127053"
],
"unii": [
"864V2Q084H"
],
"rxcui": [
"197361",
"308135",
"308136"
],
"spl_set_id": [
"5409b296-3bed-47cd-abba-9fe6f6833af6"
],
"manufacturer_name": [
"Cipla USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69097-127_7cbe66f6-99fb-403f-9c6b-e4ecc7549eaf"